Rossby Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Rossby Financial's REGN Position: Q2 2026 in Review

Rossby Financial increased its Regeneron Pharmaceuticals (REGN) stake by 92% in Q2 2026, buying an estimated $79K and bringing the position to 242 shares worth $151K. The position accounts for 0.03% of the portfolio, ranked #449.

Rossby Financial first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

• Rossby Financial held 242 shares of Regeneron Pharmaceuticals worth $151K as of Q2 2026.
• Rossby Financial bought 116 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $79K.
• Regeneron Pharmaceuticals made up 0.03% of Rossby Financial's portfolio in Q2 2026, its #449 holding.
• Rossby Financial first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
• 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.